Triple combination penicillin-vancomycin-gentamicin for experimental endocarditis caused by a highly penicillin-and glycopeptide-resistant isolate of Enterococcus faecium.

A combination of low-dose penicillin (75,000 IU/kg twice daily [b.i.d.]) vancomycin (30 mg/kg b.i.d.) and gentamicin (6 mg/kg b.i.d.) has been shown to be as effective as a combination of high-dose penicillin (500,000 IU/kg b.i.d.) and gentamicin (6 mg/kg b.i.d.) in the treatment of rabbit endocarditis caused by an Enterococcus faecium strain moderately resistant to beta-lactams and highly resistant to glycopeptides. The same regimens were evaluated against an E. faecium strain highly resistant to both penicillin (MIC, 128 micrograms/mL) and vancomycin (MIC, 512 micrograms/mL). High doses of penicillin-gentamicin and vancomycin-gentamicin had no effect in in vitro killing-curve studies or in rabbits after treatment for 5 days. High doses of penicillin-vancomycin were only bacteriostatic in killing curves and provided a small reduction in the bacterial titers of the vegetations. In contrast, high-dose penicillin-vancomycin-gentamicin was bactericidal in vitro and highly effective in treating rabbits. However, the emergence of a bacterial subpopulation resistant to the synergistic effect of penicillin and vancomycin could reduce the clinical utility of this combination.

[1]  J. Lemeland,et al.  Daptomycin or teicoplanin in combination with gentamicin for treatment of experimental endocarditis due to a highly glycopeptide-resistant isolate of Enterococcus faecium , 1992, Antimicrobial Agents and Chemotherapy.

[2]  G. Eliopoulos,et al.  Absence of synergistic activity between ampicillin and vancomycin against highly vancomycin-resistant enterococci , 1992, Antimicrobial Agents and Chemotherapy.

[3]  G. Woods,et al.  Hospital-acquired Infection with Vancomycin-resistant Enterococcus faecium Transmitted by Electronic Thermometers , 1992, Annals of Internal Medicine.

[4]  J. Boyce,et al.  Emergence and nosocomial transmission of ampicillin-resistant enterococci , 1992, Antimicrobial Agents and Chemotherapy.

[5]  S. Handwerger,et al.  Concomitant high-level vancomycin and penicillin resistance in clinical isolates of enterococci. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  L. Gutmann,et al.  Replacement of the essential penicillin-binding protein 5 by high-molecular mass PBPs may explain vancomycin-beta-lactam synergy in low-level vancomycin-resistant Enterococcus faecium D366. , 1992, FEMS microbiology letters.

[7]  J. Heijenoort,et al.  Inducible carboxypeptidase activity in vancomycin-resistant enterococci , 1992, Antimicrobial Agents and Chemotherapy.

[8]  L. Gutmann,et al.  Synergistic killing of vancomycin-resistant enterococci of classes A, B, and C by combinations of vancomycin, penicillin, and gentamicin , 1991, Antimicrobial Agents and Chemotherapy.

[9]  J. Duval,et al.  Effects of combinations of beta-lactams, daptomycin, gentamicin, and glycopeptides against glycopeptide-resistant enterococci , 1991, Antimicrobial Agents and Chemotherapy.

[10]  N. Woodford,et al.  Resistance to vancomycin and teicoplanin: an emerging clinical problem , 1990, Clinical Microbiology Reviews.

[11]  L. Gutmann,et al.  Mechanism of resistance to vancomycin in Enterococcus faecium D366 and Enterococcus faecalis A256 , 1990, Antimicrobial Agents and Chemotherapy.

[12]  D. Shlaes,et al.  Inducible resistance to vancomycin in Enterococcus faecium D366. , 1989, The Journal of infectious diseases.

[13]  B. Fantin,et al.  Ceftriaxone-netilmicin combination in single-daily-dose treatment of experimental Escherichia coli endocarditis , 1989, Antimicrobial Agents and Chemotherapy.

[14]  D. Shlaes,et al.  Inducible, transferable resistance to vancomycin in Enterococcus faecalis A256 , 1989, Antimicrobial Agents and Chemotherapy.

[15]  J. Duval,et al.  Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. , 1988, The New England journal of medicine.

[16]  A. Kaplan,et al.  Recovery of resistant enterococci during vancomycin prophylaxis , 1988, Journal of clinical microbiology.

[17]  Claude Carbón,et al.  Value of antibiotic levels in serum and cardiac vegetations for predicting antibacterial effect of ceftriaxone in experimental Escherichia coli endocarditis , 1987, Antimicrobial Agents and Chemotherapy.

[18]  B. Murray,et al.  beta-Lactamase production in experimental endocarditis due to aminoglycoside-resistant Streptococcus faecalis. , 1987, The Journal of infectious diseases.

[19]  L. Gutmann,et al.  Use of penicillin-binding proteins for the identification of enterococci. , 1986, Journal of general microbiology.

[20]  Claude Carbón,et al.  Comparison of penicillin and vancomycin, individually and in combination with gentamicin and amikacin, in the treatment of experimental endocarditis induced by nutritionally variant streptococci , 1985, Antimicrobial Agents and Chemotherapy.

[21]  L. Gutmann,et al.  One or two low affinity penicillin-binding proteins may be responsible for the range of susceptibility of Enterococcus faecium to benzylpenicillin. , 1985, Journal of general microbiology.

[22]  M. Sande,et al.  Penicillin therapy for treatment of experimental endocarditis caused by viridans streptococci in animals. , 1985, The Journal of infectious diseases.

[23]  M. Levison,et al.  Minimal concentrations of aminoglycoside that can synergize with penicillin in enterococcal endocarditis , 1981, Antimicrobial Agents and Chemotherapy.

[24]  James H. Torrie,et al.  Principles and procedures of statistics: a biometrical approach (2nd ed) , 1980 .

[25]  A. Kucers.  Use of Antibiotics , 1979 .

[26]  R. Facklam.  Recognition of group D streptococcal species of human origin by biochemical and physiological tests. , 1972, Applied microbiology.

[27]  D. Durack,et al.  Experimental Bacterial Endocarditis: II. Survival of Bacteria in Endocardial Vegetations , 1972 .

[28]  B. Perlman,et al.  Experimental endocarditis. II. Staphylococcal infection of the aortic valve following placement of a polyethylene catheter in the left side of the heart. , 1971, The Yale journal of biology and medicine.